Findings and Side-effects of Flexible Endoscopic Evaluation of Swallowing - the FEES-Registry
FEES-Registry
1 other identifier
observational
2,401
1 country
1
Brief Summary
Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. The FEES-Registry aims at evaluating findings and side effects of FEES in a heterogeneous collective of patients with neurogenic dysphagia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedNovember 29, 2019
November 1, 2019
2.8 years
January 12, 2017
November 27, 2019
Conditions
Outcome Measures
Primary Outcomes (7)
FEES-related side effects - 1. systolic blood pressure increase
Systolic blood pressure will be measured directly prior, during and after the procedure. The initial value will be compared to the highest blood pressure value measured during/directly after the procedure.
during the procedure
FEES-related side effects - 2. Oxygen saturation decline
Oxygen saturation will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure.
during the procedure
FEES-related side effects - 3. Heart rate decrease
Heart rate will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure.
during the procedure
FEES-related side effects - 4. Nose bleed
Number of patients with nose bleed during the procedure
during the procedure
FEES-related side effects - 5. Laryngospasm
Number of patients with laryngospasm during the procedure
during the procedure
FEES-related side effects - 6. Decreased level of consciousness
Number of patients with a decline in consciousness during the procedure (measured with the Richmond agitation and sedation scale)
during the procedure
Patients subjective FEES-related discomfort
Number of patients with procedure related discomfort measured with a 4 point scale ranging from 1=no discomfort to 4=extremely painful sensation during the procedure
during the procedure
Secondary Outcomes (1)
Changes of dietary status after FEES
immediately prior and immediately after the procedure
Interventions
Eligibility Criteria
Patients with suspected neurogenic dysphagia
You may qualify if:
- suspected neurogenic dysphagia
- Patients being scheduled for a FEES
- written informed consent
You may not qualify if:
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Münster, 48149, Germany
Related Publications (1)
Dziewas R, Auf dem Brinke M, Birkmann U, Brauer G, Busch K, Cerra F, Damm-Lunau R, Dunkel J, Fellgiebel A, Garms E, Glahn J, Hagen S, Held S, Helfer C, Hiller M, Horn-Schenk C, Kley C, Lange N, Lapa S, Ledl C, Lindner-Pfleghar B, Mertl-Rotzer M, Muller M, Neugebauer H, Ozsucu D, Ohms M, Perniss M, Pfeilschifter W, Plass T, Roth C, Roukens R, Schmidt-Wilcke T, Schumann B, Schwarze J, Schweikert K, Stege H, Theuerkauf D, Thomas RS, Vahle U, Voigt N, Weber H, Werner CJ, Wirth R, Wittich I, Woldag H, Warnecke T. Safety and clinical impact of FEES - results of the FEES-registry. Neurol Res Pract. 2019 Apr 26;1:16. doi: 10.1186/s42466-019-0021-5. eCollection 2019.
PMID: 33324882DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Rainer Dziewas, MD
University Hospital Muenster, Department of Neurology, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 31, 2017
Study Start
October 1, 2014
Primary Completion
August 1, 2017
Study Completion
October 1, 2017
Last Updated
November 29, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share